Digital repository of Slovenian research organisations

Show document
A+ | A- | SLO | ENG

Title:Priporočila za obravnavo diareje ob sistemskem onkološkem zdravljenju
Authors:Hribernik, Nežka (Author)
Reberšek, Martina (Author)
Language:Slovenian
Tipology:1.04 - Professional Article
Organisation:Logo OI - Institute of Oncology
Keywords:diareja, bolniki, onkološki bolniki, sistemsko zdravljenje
Year of publishing:2014
COBISS_ID:1963899 Link is opened in a new window
UDC:616-006
ISSN on article:1408-1741
OceCobissID:65324032 Link is opened in a new window
URN:URN:NBN:SI:doc-1H6ZBV3U
Views:1570
Downloads:332
Files:.pdf PDF - Presentation file, download (446,90 KB)
 
Journal:Onkologija
Onkološki inštitut
 
Metadata:XML RDF-CHPDL DC-XML DC-RDF
Rights:by Authors
:
  
Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.


Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:31.08.2018

Secondary language

Language:Undetermined
Title:Recommendations for diarrhea in systemic oncology treatment
Abstract:Diarrhea is defined as frequent passages of loose, unformed or liquid stool more than three times in 24 hours. It is one of the most common undesirable symptoms, which oncology patients face. Diarrhea can lead to dehydration, electrolytic and metabolic disorders, kidney failure and in severe cases also hemodynamic instability, which requires hospitalisation. The problem can affect the uninterrupted course of a specific cancer treatment and influence the quality of life of patients, reduce compliance to treatment and shorten the survival period. General recommendations for diarrhea in cancer treatment were first published in 1998, amended and adapted in 2004 in the Journal of Clinical Oncology (1). So far there are no updated, internationally accepted instructions. The article summarises the recognised and generally adopted recommendations, with differences in treatments of diarrhea with cytostatic and target medications.

Archive

niGradiv

Back